Literature DB >> 18368204

A cohort study to assess the new WHO Japanese encephalitis surveillance standards.

Tom Solomon1, Thi Thu Thao, Penny Lewthwaite, Mong How Ooi, Rachel Kneen, Nguyen Minh Dung, Nicholas White.   

Abstract

OBJECTIVE: To assess the field-test version of the new WHO Japanese encephalitis (JE) surveillance standards.
METHODS: We applied the clinical case definition of acute encephalitis syndrome (AES), laboratory diagnostic criteria and case classifications to patients with suspected central nervous system (CNS) infections in southern Viet Nam.
FINDINGS: Of the 380 patients (149 children) recruited with suspected CNS infections, 296 (96 children) met the AES case definition. 54 children were infected with JE virus (JEV), of whom 35 (65%) had AES, giving a sensitivity of 65% (95% CI: 56-73) and specificity of 39% (95% CI: 30-48). Nine adults with JEV presented with AES. 19 JEV-infected children missed by surveillance included 10 with acute flaccid paralysis, two with flaccid hemiparesis and six with meningism only. Altering the case definition to include limb paralysis and meningism improved sensitivity to 89% (95% CI: 83-95), while reducing specificity to 23% (95% CI: 15-30). Six children that did not have AES on admission had reduced consciousness after admission. Cerebrospinal fluid (CSF) analysis diagnosed seven patients negative on serum analysis. Five patients with neurological manifestations of dengue infection had JEV antibodies in serum and would have been misdiagnosed had we not tested for dengue antibodies in parallel.
CONCLUSION: Children infected with JEV that presented with acute limb paralysis or neck stiffness only were missed by the surveillance standards, although some of them subsequently became encephalopathic. A footnote in the surveillance standards drawing attention to these presentations would be helpful. An acute CSF sample is more sensitive and specific than an acute serum sample.

Entities:  

Mesh:

Year:  2008        PMID: 18368204      PMCID: PMC2647413          DOI: 10.2471/blt.07.043307

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  23 in total

1.  A case of Japanese encephalitis: CT and MRI findings in acute and convalescent stages.

Authors:  A Nakashima; Y Horichi; Y Takagi; S Miyamoto; S Takashima; H Inoue
Journal:  Radiat Med       Date:  1999 Sep-Oct

Review 2.  The epidemiology of Japanese encephalitis: prospects for prevention.

Authors:  D W Vaughn; C H Hoke
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

3.  Neurological manifestations of dengue infection.

Authors:  T Solomon; N M Dung; D W Vaughn; R Kneen; L T Thao; B Raengsakulrach; H T Loan; N P Day; J Farrar; K S Myint; M J Warrell; W S James; A Nisalak; N J White
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

4.  Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line.

Authors:  C J Leake; D S Burke; A Nisalak; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1986-09       Impact factor: 2.345

5.  Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid.

Authors:  D S Burke; A Nisalak; M A Ussery; T Laorakpongse; S Chantavibul
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

6.  Fatal outcome in Japanese encephalitis.

Authors:  D S Burke; W Lorsomrudee; C J Leake; C H Hoke; A Nisalak; V Chongswasdi; T Laorakpongse
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

7.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

8.  Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.

Authors:  Peter M Winter; Nguyen Minh Dung; Ha Thi Loan; Rachel Kneen; Bridget Wills; Le Thi Thu; Deborah House; Nicholas J White; Jeremy J Farrar; C Anthony Hart; Tom Solomon
Journal:  J Infect Dis       Date:  2004-09-29       Impact factor: 5.226

9.  Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay.

Authors:  D S Burke; A Nisalak
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

10.  Clinical and immunological risk factors for severe disease in Japanese encephalitis.

Authors:  Daniel H Libraty; Ananda Nisalak; Timothy P Endy; Saroj Suntayakorn; David W Vaughn; Bruce L Innis
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Mar-Apr       Impact factor: 2.184

View more
  35 in total

1.  Seroprevalence of Cysticercus Antibodies in Japanese Encephalitis Patients in Upper Assam, India: A Hospital Based Study.

Authors:  Saurav Jyoti Patgiri; Himangshu Mazumdar; Lahari Saikia
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Investigation of the genotype III to genotype I shift in Japanese encephalitis virus and the impact on human cases.

Authors:  Na Han; James Adams; Wei Fang; Si-Qing Liu; Simon Rayner
Journal:  Virol Sin       Date:  2015-08-18       Impact factor: 4.327

Review 3.  Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination.

Authors:  John P Caldwell; Lin H Chen; Davidson H Hamer
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Epidemiological Features of Japanese Encephalitis in Taiwan from 2000 to 2014.

Authors:  Yu-Kang Chang; Hsiao-Ling Chang; Ho-Sheng Wu; Kow-Tong Chen
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

5.  Central Nervous System Infection Associated with Orientia tsutsugamushi in South Korea.

Authors:  Han Sang Lee; Jun-Sang Sunwoo; Seon-Jae Ahn; Jangsup Moon; Jung-Ah Lim; Jin-Sun Jun; Woo-Jin Lee; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Sang Kun Lee; Kon Chu
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

6.  Clinical Characteristics of Severe Japanese Encephalitis: A Case Series from South Korea.

Authors:  Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Jangsup Moon; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Am J Trop Med Hyg       Date:  2017-08       Impact factor: 2.345

7.  Establishment of an Algorithm Using prM/E- and NS1-Specific IgM Antibody-Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Japanese Encephalitis Virus and West Nile Virus Infections in Humans.

Authors:  Jedhan U Galula; Gwong-Jen J Chang; Shih-Te Chuang; Day-Yu Chao
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

8.  Clinical presentation, etiology, and survival in adult acute encephalitis syndrome in rural Central India.

Authors:  Rajnish Joshi; Pradyumna Kumar Mishra; Deepti Joshi; S R Santhosh; M M Parida; Prabha Desikan; Nitin Gangane; S P Kalantri; Arthur Reingold; John M Colford
Journal:  Clin Neurol Neurosurg       Date:  2013-05-01       Impact factor: 1.876

9.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090

10.  Japanese encephalitis-a pathological and clinical perspective.

Authors:  Debapriya Ghosh; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.